Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
tPA and DNase vs Thoracoscopy for Severe Pleural Infection
NCT03213834Phase 4Completed
- Sponsor
- University of Florida
- Start
- Sep 2017
- Primary completion
- Feb 2020
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of tissue-plasminogen activator, dornase alfa in Complicated parapneumonic effusion (cPPE), pleural empyema, sponsored by University of Florida. Started Sep 2017; status: completed.
02
Drugs
tissue-plasminogen activatordornase alfa
03
Conditions
Complicated parapneumonic effusion (cPPE)pleural empyema
Beyond the preview
Go deeper on NCT03213834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03213834.